Help us to stop prostate diseases ruining lives
Prostate medical news > Earlier news
 |
| March 2006 m SALVAGE RADIATION THERAPY FOR PSA RECURRENCE FOLLOWING RADICAL PROSTATECTOMY: TEN YEAR OUTCOME ESTIMATES AND IDENTIFICATION OF FACTORS THAT PREDICT RESPONSE Statistics derived from an ongoing 20 year study. Reported by: Professor Roger Kirby |
|
| March 2006 PROGRESSION-FREE SURVIVAL RATES IN MEN TREATED WITH RADICAL PROSTATECTOMY DIAGNOSED USING A CUTOFF POINT OF 2.6ng/ml A comparison of outcomes using 2.6ng/ml and 4.0ng/ml News Report by: Christopher P. Evans, M.D. |
|
| March 2006 TREATMENT FOR PROSTATE CANCER VERSUS OBSERVATION, HELPS OLDER MEN LIVE LONGER A new study shows older men with early stage prostate cancer survive longer if they are treated versus not being treated in favour of the "watchful waiting" approach. News Report by: Karen Mallet |
|
| March 2006 A POSSIBLE VIRAL CAUSE FOR PROSTATE CANCER? Excitement at the 2006 Prostate Cancer Symposium in San Francisco: reports of a possible virus in humans associated with the development of prostate cancer. Article reviewed by Mr Tom Swallow |
|
| March 2006 m ALFUZOSIN MAY IMPROVE DOUBLE-J STENT RELATED SYMPTOMS The administration of a selective alpha1-blocker, such as alfuzosin, improves stent-related urinary symptoms and pain. In addition, it was demonstrated that patients' sexual function and general health were better preserved. News Report by: Michael J. Metro, MD |
|
| March 2006 NUTRITIONAL ANTIOXYDANTS AND PROSTATE CANCER RISK Are nutritional supplements worthwhile? News Report by: Christopher P. Evans, M.D. |
|
| March 2006 RESEARCHERS FIND BETTER PROSTATE CANCER INDICATORS "We hope that in addition to being a valuable diagnostic and prognostic tool, our discoveries about these genes will help us develop new treatments for prostate cancer," said chief researcher Dr Donkena News Report by: Elizabeth Zimmermann |
|
| February 2006 PROSTATE TESTS: NOT PERFECT BUT STILL VITAL Research criticising the PSA test is unhelpful. It should be seen as the first in a series of checks to provide a more precise diagnosis. Contributed by Dr Thomas Stuttaford OBE |
|
| February 2006 m (IGF1) GENE MAY BE ASSOCIATED WITH THE RISK OF PROSTATE CANCER A new study in the USA suggests a possible link. Reported by: Professor Roger Kirby |
|
| February 2006 m REHABILITATION OF ERECTILE FUNCTION FOLLOWING RADICAL PROSTATECTOMY A small study suggests that an early rehabilitation program can help to restore erectile function. Article reviewed by Mr Tom Swallow |
|
| February 2006 CHANGING TIMES FOR MEN WITH PROSTATE CANCER An overview of current thinking. Contributed by: Professor Roger Kirby |
|
| February 2006 RANDOMIZED TRIAL OF SAW PALMETTO VERSUS PLACEBO SUGGESTS NO BENEFIT Result of a Californian study for BPH sufferers. Reported by: Professor Roger Kirby |
|
| February 2006 MAKING SENSE OF THE PSA TEST FOR PROSTATE CANCER. Article by The Institute of Cancer Research based on work by Dr Jane Melia. Reported by: Professor Roger Kirby |
|
| January 2006 THE PROSTATE CANCER PATIENT'S DILEMMA Nobody should have cancer treatment without a confirmed diagnosis - but can the diagnosis be made too early? Contributed by Dr Mark R Feneley |
|
| January 2006 WHERE MEN LOSE OUT Article from The Guardian, 3rd November 2005. Reported by Dr Simon Atkins |
|
| January 2006 LETTER TO THE EDITOR OF THE TIMES From our Chairman. Professor Roger Kirby |
|
| January 2006 FAST-TRACK REVIEW SYSTEM INTRODUCED BY NICE A quicker approval of new drugs - including one for hormone-refractory prostate cancer. Forwarded by: John Anderson, CEO, Prostate Research Campaign UK |
|
| January 2006 m BREAKING THE MOLECULAR CODE FOR PROSTATE CANCER The fundamental scientific question, still unanswered, addresses the molecular differences that determine the ability of early stage disease to metastasise. Contributed by Dr Mark R Feneley |
|
| January 2006 PROSTATE CANCER SCREENING MAY NOT REDUCE MORTALITY Article by Dr John Concato of Veterans Administration, Connecticut, USA. Contributed by: Professor Roger Kirby |
|
| December 2005 m LONG TERM CASODEX (BICALUTAMIDE) TREATMENT IN VITRO RESULTS IN ALTERED ANDROGEN RECEPTOR MEDIATED SIGNALING IN PROSTATE CANCER CELLS A rise in PSA after Casodex may still respond to treatment. Contributed by Professor Roger Kirby |
|
| December 2005 m DO STATINS HAVE A ROLE TO PLAY IN PROSTATE CANCER? Preliminary results look promising. Contributed by Mr M. Goldstraw |
|
| December 2005 VARIATIONS IN LOCALISED PROSTATE CANCER THERAPY BASED ON SOCIOECONOMICS AND ETHNICITY US study shows that ethnicity, income and geography can all affect treatment given. Contributed by Professor Roger Kirby |
|
| November 2005 THE NEED TO REDUCE PATIENT DISCOMFORT DURING TRANSRECTAL ULTRASONOGRAPHY-GUIDED PROSTATE BIOPSY: WHAT DO WE KNOW? Article from British Journal of Urology International. Contributed by Professor Roger Kirby |
|
| November 2005 DR THOMAS STUTTAFORD ANSWERS YOUR QUESTIONS ON PROSTATE CANCER Answers to some more Frequently Asked Questions. Contributed by Dr Thomas Stuttaford OBE |
|
| November 2005 m SHORT-TERM ANDROGEN DEPRIVATION AND RADIOTHERAPY FOR LOCALLY ADVANCED PROSTATE CANCER: RESULTS FROM THE TRANS-TASMAN RADIATION ONCOLOGY GROUP 96.01 RANDOMISED CONTROLLED TRIAL Results of a ten year trial suggest a way to an improved outcome. Reviewed by Mr Amit Patel |
|
| November 2005 INCIDENCE AND MANAGEMENT OF GYNAECOMASTIA IN MEN TREATED FOR PROSTATE CANCER A study of incidence and effects. Reviewed by Mr Joe Nariculum |
|
| October 2005 FIRST HIGHLIGHTS OF THE 4TH BIENNIAL WORLD CONGRESS ON MEN'S HEALTH AND GENDER Conference report - Vienna 30 September - 1 October 2005. Forwarded by Professor Roger Kirby |
|
| October 2005 ASSESSING THE IMPLICATIONS OF A PSA RISE AFTER RADICAL PROSTATECTOMY A look at outcomes. Reviewed by Dr Charlotte Foley |
|
| October 2005 ANNUAL PROSTATE CANCER SCREENING TEST APPEARS TO SAVE LIVES Nearly three times less likely to die. Forwarded by: John Anderson, CEO, Prostate Research Campaign UK |
|
| October 2005 m TWO MORE MARKERS TO POTENTIALLY SUPERCEDE PSA AS A MARKET FOR PROSTATE CANCER Finding from a randomised controlled trial in Italy. Reviewed by Dr Charlotte Foley |
|
| September 2005 DELAYS ON RECEIVING RADIOTHERAPY AFTER A DIAGNOSIS OF PROSTATE CANCER DO AFFECT OUTCOME FOR THOSE WITH HIGH RISK DISEASE. Finding from a randomised controlled trial in Italy. Reviewed by Dr Charlotte Foley |
|
| September 2005 HAS THE QUALITY OF LIFE BEEN CONSIDERED AFTER TREATMENT FOR PROSTATE CANCER? Radical prostatectomy versus high-dose rate brachytherapy - compared. Reviewed by Dr Tom Swallow |
|
| September 2005 m TAMOXIFEN IS BETTER THAN RADIOTHERAPY FOR BICALUTAMIDE INDUCED BREAST SIDE EFFECTS. Finding from a randomised controlled trial in Italy. Reviewed by Dr Charlotte Foley |
|
| August 2005 m RANDOMISED, OPEN LABEL, PROSPECTIVE STUDY SUGGESTS ZOLEDRONIC ACID MAY PREVENT THE DEVELOPMENT OF BONE METASTASES IN PATIENTS WITH ADVANCED CANCER Study suggests that bisphosphonates may be associated with a reduction in bone metastases in patients with cancer. Reported by Professor Roger Kirby |
|
| August 2005 m POSTOPERATIVE RADIOTHERAPY AFTER RADICAL PROSTATECTOMY: A RANDOMISED CONTROLLED TRIAL Progression-free survival was significantly improved. Reported by Mr Joe Nariculam |
|
| June 2005 EARLY PROSTATE CANCER SCREENING MAY REDUCE MORTALITY RATE BY 35% An unexpected result from Public Health officials. Reported by Professor Roger Kirby |
|
| June 2005 DOES AGE MAKE A DIFFERENCE IN PSA RECURRENCE AFTER RADICAL PROSTATECTOMY? Age is not the main factor. Reviewed by Dr Tom Swallow |
|
| June 2005 m CONTRIBUTION OF RADIOTHERAPY VOLUME AND ANDROGEN DEPRIVATION TO ACUTE RECTAL AND URINARY TOXICITY IN PATIENTS UNDERGOING PROSTATE CANCER TREATMENT Nothing without side effects. Article by Professor Roger Kirby |
|
| June 2005 CONSERVATIVE MANAGEMENT OF CLINICALLY LOCALISED PROSTATE CANCER — A 20 YEAR FOLLOW UP The Gleason score is found to be a good marker Reviewed by Mr J Bhardwa |
|
| June 2005 THE COMPLETE GUIDE TO OVERCOMING PROSTATE CANCER, PROSTATITIS AND BPH A new publication by Peter Scardino and Judith Kelman Book review by Iain Millett |
|
| June 2005 m THE USE OF RADIATION TO ALLEVIATE BONE CANCER PAIN A single or multiple dose approach? Reported by John Anderson |
|
| May 2005 WATCHFUL WAITING VERSUS RADICAL PROSTATECTOMY Swedish study suggests that surgery is a better choice Conference report by Professor Roger Kirby |
|
| May 2005 REGULAR VIGOROUS ACTIVITY COULD SLOW PROGRESSION OF PROSTATE CANCER Lowers risk of high grade, advanced or fatal disease Conference report by Professor Roger Kirby |
|
| May 2005 PSA TEST MAY NOT BE SO USELESS - AFTER ALL New findings are reported Conference report by Professor Roger Kirby |
|
| May 2005 IF THE PSA RISES AFTER TREATMENT A review of the options Article by Professor Roger Kirby |
|
| May 2005 GLAND ON THE RUN Article from The Observer, 8th May 2005. Reported by Simon Garfield |
|
| April 2005 RADIATION FOR PROSTATE CANCER INCREASES THE RISK OF RECTAL CANCER Risk is quite low but patients need to be aware Article by Professor Roger Kirby |
|
| April 2005 ROBOTIC SURGERY IN THE UK: ESTABLISHING A PROGRAMME AND THE EMERGING ROLE New treatment in its early stages Reviewed by Mr Zach Dovey |
|
| April 2005 ACTIVE SURVEILLANCE FOR EARLY PROSTATE CANCER The background story Reported by Mr Majid Shabbir |
|
| April 2005 SEXUAL, PSYCHOLOGICAL AND DYADIC QUALITIES OF THE PROSTATE CANCER "COUPLE" Looking beyond the patient alone Reviewed by Mr Zach Dovey |
|
| April 2005 m GONADATROPHIN RELEASING HORMONE ANALOGUES CAUSE OSTEOPOROSIS AND AN INCREASED RISK OF FRACTURE Careful consideration is required when using this treatment Reported by Dr Charlotte Foley |
|
| March 2005 m SALVAGE CRYOSURGERY FOR LOCALLY RECURRENT PROSTATE CANCER FOLLOWING RADIOTHERAPY The long-term outcomes have still to be measured Reviewed by Mr J Bhardwa |
|
| March 2005 WHAT TO EXPECT WHEN PSA REMAINS DETECTABLE AFTER RADICAL PROSTATECTOMY Gleason and rate of rise are predictors Reported by Dr Charlotte Foley |
|
| March 2005 EFFECT OF AGE AND CO-MORBIDITY ON SURVIVAL AND TREATMENT OF PROSTATE CANCER Longer life expectancy requires some new approaches Reviewed by Mr J Bhardwa |
|
| March 2005 m CHEMOTHERAPY FOR HORMONE-ESCAPED PROSTATE CANCER A new Gold Standard Reported by Dr Charlotte Foley |
|
| March 2005 NATIONAL AUDIT OFFICE REPORT ON CANCER SERVICES IN ENGLAND Disturbing reading for men afflicted with prostate cancer and their families Editorial by John Anderson |
|
| February 2005 EACH GLASS OF RED WINE DRUNK BY A MIDDLE AGED MAN MAY REDUCE HIS RISK OF PROSTATE CANCER This health promotion measure is more palatable than some! Reported by Dr Charlotte Foley |
|
| February 2005 CAN PROSTATE CANCER BE PREVENTED? Some recommendations which may help. Article by Professor Roger Kirby |
|
| February 2005 CHEMOPREVENTION OF PROSTATE CANCER: THE REDUCE TRIAL Can dutasteride lower the risk of developing prostate cancer? Reported by Mr Majid Shabbir |
|
| February 2005 FOCAL THERAPY IN PROSTATE CANCER: FUTURE TRENDS Developments towards a "lumpectomy" for prostate cancer. Reviewed by Mr Zach Dovey |
|
| January 2005 LAPAROSCOPIC AND ROBOTIC RADICAL PROSTATECTOMY : WHAT ARE THE REAL ADVANTAGES ? The evidence is mounting. Reviewed by Mr Zach Dovey |
|
| November 2004 m TRANSURETHERAL MICROWAVE THERMOTHERAPY (TUMT) VS TRANSURETHERAL RESECTION (TURP) FOR TREATING BENIGN PROSTATIC HYPERPLASIA: A SYSTEMATIC REVIEW The differences explained. Reviewed by Mr Zach Dovey |
|
| November 2004 m COMPARING BRACHYTHERAPY AND RADICAL PERINEAL PROSTATECTOMY FOR ORGAN CONFINED PROSTATE CANCER A carefully controlled comparison. Reviewed by Mr J Bhardwa |
|
| November 2004 m REDUCING THE RISK OF SPREAD IN PATIENTS WITH LOCALLY ADVANCED PROSTATE CANCER The initial findings of this report suggest that Bicalutamide may benefit some patients. Reviewed by Mr J Bhardwa |
|
| November 2004 HIGH INTENSITY FOCUSSED ULTRASOUND (HIFU) - A POSSIBLE NEW TREATMENT FOR EARLY PROSTATE CANCER UK trials of this non-invasive treatment are due to start in January 2005. Reported by John Anderson |
|
| November 2004 NHS REPORT - "MAKING PROGRESS ON PROSTATE CANCER" A major report delivered to the National Prostate Cancer Conference, November 2004. Reported by John Anderson |
|
| October 2004 THE PSA TEST IS NOT USELESS, AFTER ALL! Although there have been changes in the relationship between the volume of prostate cancer and PSA, it is still a useful marker. Reported by Professor Roger Kirby |
|
| October 2004 PRE-OPERATIVE PSA VELOCITY AND THE RISK OF DEATH FROM PROSTATE CANCER AFTER RADICAL RETROPUBIC PROSTATECTOMY A knowledge of the PSA velocity may help to prevent wasted operations. Reported by Dr Claire Taylor |
|
| October 2004 SEXUAL ACTIVITY AND PROSTATE CANCER: IS THERE A LINK? Too much sex may not be a bad thing - at least for the prostate. Reported by Mr Majid Shabbir |
|
| October 2004 ASPIRIN CAN HELP PROSTATE CANCER VICTIMS LIVE LONGER, SAY SCIENTISTS Article from The Scotsman, 5th October 2004. Reported by Angus Howarth |
|
| October 2004 IS A BONE SCAN INDICATED IF THE PSA RISES AFTER RADICAL PROSTATECTOMY Findings suggest that a bone scan is indicated if the PSA rises above 7ng/ml after radical prostatectomy. Reviewed by Mr J Bhardwa |
|
| September 2004 THE PATIENT JOURNEY The patient journey underlines the need to treat patients rather than diseases and to understand the impact this has on patient's carers and families. Reported by Dr Peter Amoroso |
|
| September 2004 m DOCETAXEL AND ZOLEDRONIC ACID IN PATIENTS WITH METASTATIC HORMONE-REFRACTORY PROSTATE CANCER Trial suggests that combined Docetaxel and Zoledronic acid is a useful treatment for metastatic HRPC. Reviewed by Mr Zach Dovey |
|
| September 2004 m THE IMMUNE SYSTEM CAN BE USED TO KILL PROSTATE CANCER USING PROSTATE SPECIFIC MEMBRANE AGENT AS A TARGET Prostate cancer ‘markers’ appear to allow ‘magic bullet’ therapies to destroy cancer cells. Reported by Dr Charlotte Foley |
|
| September 2004 m THE EFFECT OF COMBINING ANDROGEN SUPPRESSION WITH RADIOTHERAPY FOR HIGH-GRADE CLINICALLY LOCALISED PROSTATE CANCER Combination drug and radiotherapy trials show improved the survival advantage. Reported by Mr Majid Shabbir |
|
| August 2004 m NERVE GRAFTING CAN IMPROVE URINARY FUNCTION AFTER RADICAL PROSTATECTOMY Trial shows evidence of improvements after sural nerve grafting. Reported by Mr Khurshid Ghani |
|
| August 2004 IMPACT OF OBESITY ON PROSTATE CANCER AND OUTCOME FROM RADICAL PROSTATECTOMY Obesity is associated with a more aggressive form of prostate cancer. Reported by Mr Majid Shabbir |
|
| August 2004 PROSTATE SPECIFIC ANTIGEN (PSA) AS A SCREENING TEST FOR PROSTATE CANCER Initial PSA value strongly associated with the subsequent detection of prostate cancer. Reported by Professor Roger Kirby |
|
| August 2004 m BOOK REVIEW OF —STENTING AND THE URINARY SYSTEM’ “Stenting and the Urinary System” is the definitive textbook for the subject. Reviewed by Dr Zach Dovey |
|
| August 2004 PSA TESTING FOR THE EARLY DETECTION OF PROSTATE CANCER What are the implications of these rather unexpected findings? Reported by Professor Roger Kirby |
|
| August 2004 m TRANSURETHERAL ELECTROVAPORISATION (TUEVP) VERSUS TRANSURETHERAL RESECTION (TURP) FOR SYMPTOMATIC PROSTATIC OBSTRUCTION : A COMPARISON. An analysis of a group of clinical trials from 1993 to 2003 comparing the two treatments. Reviewed by Mr Zach Dovey |
|
| August 2004 BOOK REVIEW OF 'PROSTATE CANCER : THE FACTS' This is a book which aims to educate the interested “layperson” to a higher level than would be found in the average pamphlet available in a Urology out-patients department. Reviewed by Mr Zach Dovey |
|